J A Kuhn1, T M McCarty. Show Affiliations » 1. Baylor University Medical Center, Department of Surgery, Dallas, Texas, USA.
Abstract
Entities: Disease
Mesh： See more » AdultAgedBiomarkers, Tumor/analysisBiopsy/methodsClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicColoring AgentsCombined Modality TherapyDisease-Free SurvivalFemaleFollow-Up StudiesHead and Neck Neoplasms/pathologyHead and Neck Neoplasms/surgeryHumansInterferon alpha-2Interferon-alpha/therapeutic useLymph Nodes/diagnostic imagingLymph Nodes/pathologyLymphatic Metastasis/diagnosisLymphatic Metastasis/diagnostic imagingMaleMelanoma/chemistryMelanoma/diagnostic imagingMelanoma/mortalityMelanoma/pathologyMelanoma/secondaryMelanoma/surgeryMelanoma/therapyMethylene BlueMiddle AgedMonophenol Monooxygenase/geneticsNeoplasm Proteins/analysisNeoplasm Proteins/geneticsNeoplasm Staging/methodsPolymerase Chain ReactionPrognosisRNA, Messenger/analysisRNA, Messenger/geneticsRNA, Neoplasm/analysisRNA, Neoplasm/geneticsRadionuclide ImagingRandomized Controlled Trials as TopicRecombinant ProteinsRetrospective StudiesSkin Neoplasms/mortalitySkin Neoplasms/pathologySkin Neoplasms/therapyStaining and LabelingSurvival AnalysisTechnetium Tc 99m Sulfur Colloid
Substances： See more » Biomarkers, TumorColoring AgentsInterferon alpha-2Interferon-alphaNeoplasm ProteinsRNA, MessengerRNA, NeoplasmRecombinant ProteinsTechnetium Tc 99m Sulfur ColloidMonophenol MonooxygenaseMethylene Blue
Year: 1999 PMID： 10999048
Source DB: PubMed Journal: Cancer Invest ISSN： 0735-7907 Impact factor: 2.176